Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-151-9 | CAS number: 557-05-1
Endpoint summary
Administrative data
Description of key information
The skin sensitization potential of target chemical was assessedin various experimental studies which were conducted on humans.Based on the available key data and supporting study,it can be concluded thatchemical is unable to cause skin sensitization and considered as not sensitizing. Comparing the above annotations with the criteria of CLP regulation, it can be classified under the category “Not Classified”.
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Various studies have been summarized to determine the extent of dermal sensitization caused by inc stearate to living organisms. These results include in vivo experimental studies for the target chemical performed on humans.
Draize Shelanski Patch test was performed to evaluate the dermal sensitization potential of ZInc stearate present in an eye shadow formulation.
The eye shadow formulation containing 10% test chemical was exposed to the skin of 99 human volunteers, and observed for dermal reactions (duration of exposure, observation period not specified).
The eye shadow formulation did not cause any dermal reactions to 99 volunteers tested.
Hence, the eye shadow formulation containing 10% zinc stearate can be considered to be not sensitizing to human skin.
This is supported by the results of another patch performed according to Schwartz-Peck Prophetic Patch Test method to evaluate the dermal sensitization potential of ZInc stearate present in an eye shadow formulation.
The eye shadow formulation containing 10% test chemical was exposed to the skin of 202 human volunteers, and observed for dermal reactions (duration of exposure, observation period not specified).
The eye shadow formulation did not cause any dermal reactions to 202 volunteers tested.
Hence, the eye shadow formulation containing 10% zinc stearate can be considered to be not sensitizing to human skin.
Available results for Zinc stearate indicate a very strong possibility of it being not sensitizing to skin.
Hence, Zinc stearate can be considered to be not sensitizing to skin.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the available data, Zinc stearate is not classified for skin sensitization according to CLP Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
